Clinical Trial Update: A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) [Phase 4]

View source ↗

Summary

Phase IV study assessing the safety and efficacy of Everolimus in Taiwanese patients with tuberous sclerosis complex-associated renal angiomyolipoma (TSC-AML). …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Angiomyolipoma
• Tuberous Sclerosis Complex

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Angiomyolipoma | Phase 4 | Status: ACTIVE_NOT_RECRUITING